News

After hitting an all-time high of $525.15 in February, AppLovin Corp.'s (NASDAQ: APP) share price tumbled more than 35%, due ...
President Donald Trump put the pharmaceutical industry on notice early Monday with the signing of his "most favored nation" ...
President Donald Trump's policies, including drug price controls and tax reforms, reflect a blend of Republican and ...
Greeks remain 'spectators' to pharmaceutical innovation. New medicines are frequently approved, but never reach patients.
After more than two decades as a Big Pharma cancer leader, Nicholas Botwood is swinging into the biotech world as the new ...
For the fiscal fourth quarter, adjusted earnings were 38 cents a share on revenue of $138.3 million, comfortably above ...